newsfilter
← Latest News
Business Wire·

Zura Bio Reports First Quarter 2025 Financial Results and Recent Corporate Updates

Advanced the Phase 2 TibuSURE clinical trial evaluating tibulizumab in adults with systemic sclerosis (SSc) Continued preparations for the planned Phase 2 trial evaluating tibulizumab in adults with hidradenitis